Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ProfoundBio
company
About
ProfoundBio is an oncology biotherapeutics company.
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2018
- Operating Status
- Active
ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$135M
ProfoundBio has raised a total of
$135M
in funding over 2 rounds. Their latest funding was raised on
Jun 2, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 2, 2022 | Series A | $70M | 1 | — | — | Detail |
| Jul 12, 2021 | Series A | $55M | 2 |
Lilly Asia Ventures
|
— | Detail |
| Feb 8, 2021 | Seed | $10M | 2 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
ProfoundBio is funded by 3 investors.
Xianfeng Qiyun
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Seed |
|
Lilly Asia Ventures
|
— | Series A |
Gaorong Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
